The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and the American Society of Clinical Oncology
Abstract
Context: ERBB2 (erb-b2 receptor tyrosine kinase 2 or HER2) is currently the only biomarker established for selection of a specific therapy for patients with advanced gastroesophageal adenocarcinoma (GEA). However, there are no comprehensive guidelines for the assessment of HER2 in patients with GEA. Objectives: To establish an evidence-based guideline for HER2 testing in patients with GEA, formalize the algorithms for methods to improve the accuracy of HER2 testing while addressing which patients and tumor specimens are appropriate, and to provide guidance on clinical decision making. Design: The College of American Pathologists (CAP), American Society for Clinical Pathology (ASCP), and the American Society of Clinical Oncology (ASCO) convened an Expert Panel to conduct a systematic review of the literature to develop an evidence-based guideline with recommendations for optimal HER2 testing in patients with GEA. Results: The Panel is proposing 11 recommendations with strong agreement from the open comment participants. Recommendations: The Panel recommends that tumor specimen(s) from all patients with advanced GEA, who are candidates for HER2-targeted therapy, should be assessed for HER2 status before the initiation of HER2-targeted therapy. Clinicians should offer combination chemotherapy and an HER2-targeted agent as initial therapy for all patients with HER2-positive advanced GEA. For pathologists, guidance is provided for morphologic selection of neoplastic tissue, testing algorithms, scoring methods, interpretation and reporting of results, and laboratory quality assurance. Conclusion: This guideline provides specific recommendations for assessment of HER2 in patients with advanced GEA while addressing pertinent technical issues and clinical implications of the results.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
Bang, Y.-J., Van Cutsem, E., Feyereislova, A., Chung, H. C., Shen, L., Sawaki, A., Lordick, F., Ohtsu, A., Omuro, Y., Satoh, T., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61121-x · Cited by 7,302
Comprehensive molecular characterization of gastric adenocarcinoma
The Cancer Genome Atlas Research Network (2014) · Nature · doi:10.1038/nature13480 · Cited by 6,498
(2012) · Hepatogastroenterology · doi:10.5754/hge12469 · Cited by 3,178
Wolff, A. C., Hammond, M. E. H., Schwartz, J. N., Hagerty, K. L., Allred, D. C., Cote, R. J., Dowsett, M., Fitzgibbons, P. L., Hanna, W. M., Langer, A., et al. (2007) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2007-131-18-asocco · Cited by 1,816
Wolff, A. C., Hammond, M. E. H., Hicks, D. G., Dowsett, M., McShane, L. M., Allison, K. H., Allred, D. C., Bartlett, J. M. S., Bilous, M., Fitzgibbons, P., et al. (2014) · Archives of Pathology and Laboratory Medicine · doi:10.5858/arpa.2013-0953-sa · Cited by 1,762
Assessment of a HER2 scoring system for gastric cancer: results from a validation study
Hofmann, M., Stoss, O., Shi, D., Büttner, R., Van De Vijver, M., Kim, W., Ochiai, A., Rüschoff, J., & Henkel, T. (2008) · Histopathology · doi:10.1111/j.1365-2559.2008.03028.x · Cited by 1,187
HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target
Gravalos, C., & Jimeno, A. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn169 · Cited by 1,184
Hammond, M. E. H., Hayes, D. F., Dowsett, M., Allred, D. C., Hagerty, K. L., Badve, S., Fitzgibbons, P. L., Francis, G., Goldstein, N. S., Hayes, M., et al. (2010) · Archives of Pathology & Laboratory Medicine · doi:10.5858/134.7.e48 · Cited by 1,042
Akiyama, T., Sudo, C., Ogawara, H., Toyoshima, K., & Yamamoto, T. (1986) · Science · doi:10.1126/science.3012781 · Cited by 796
Tanner, M., Hollmén, M., Junttila, T. T., Kapanen, A. I., Tommola, S., Soini, Y., Helin, H., Salo, J., Joensuu, H., Sihvo, E., et al. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi064 · Cited by 665
Satoh, T., Xu, R.-H., Chung, H. C., Sun, G.-P., Doi, T., Xu, J.-M., Tsuji, A., Omuro, Y., Li, J., Wang, J.-W., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.6136 · Cited by 624
Hecht, J. R., Bang, Y.-J., Qin, S. K., Chung, H. C., Xu, J. M., Park, J. O., Jeziorski, K., Shparyk, Y., Hoff, P. M., Sobrero, A., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.62.6598 · Cited by 624
HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer
Van Cutsem, E., Bang, Y.-J., Feng-yi, F., Xu, J. M., Lee, K.-W., Jiao, S.-C., Chong, J. L., López-Sanchez, R. I., Price, T., Gladkov, O., et al. (2015) · Gastric Cancer · doi:10.1007/s10120-014-0402-y · Cited by 608
Effect of formalin tissue fixation and processing on immunohistochemistry
Werner, M., Chott, A., Fabiano, A., & Battifora, H. (2000) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200007000-00014 · Cited by 598
HER2 testing in gastric cancer: a practical approach
Rüschoff, J., Hanna, W., Bilous, M., Hofmann, M., Osamura, R. Y., Penault-Llorca, F., van de Vijver, M., & Viale, G. (2012) · Modern Pathology · doi:10.1038/modpathol.2011.198 · Cited by 595
Rüschoff, J., Dietel, M., Baretton, G., Arbogast, S., Walch, A., Monges, G., Chenard, M.-P., Penault-Llorca, F., Nagelmeier, I., Schlake, W., et al. (2010) · Virchows Archiv · doi:10.1007/s00428-010-0952-2 · Cited by 486
Janjigian, Y. Y., Werner, D., Pauligk, C., Steinmetz, K., Kelsen, D. P., Jäger, E., Altmannsberger, H. M., Robinson, E., Tafe, L. J., Tang, L. H., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mds104 · Cited by 356
Self-citationBoku, N. (2014) · Gastric Cancer · doi:10.1007/s10120-013-0252-z · Cited by 351
Gastric cancer: ESMO–ESSO–ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Waddell, T., Verheij, M., Allum, W., Cunningham, D., Cervantes, A., & Arnold, D. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt344 · Cited by 303
Fitzgibbons, P. L., Bradley, L. A., Fatheree, L. A., Alsabeh, R., Fulton, R. S., Goldsmith, J. D., Haas, T. S., Karabakhtsian, R. G., Loykasek, P. A., Marolt, M. J., et al. (2014) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2013-0610-cp · Cited by 280
Grabsch, H., Sivakumar, S., Gray, S., Gabbert, H. E., & Müller, W. (2010) · Analytical Cellular Pathology · doi:10.1155/2010/519498 · Cited by 263
Recommended Principles and Practices for Validating Clinical Molecular Pathology Tests
Jennings, L., Van Deerlin, V. M., & Gulley, M. L. (2009) · Archives of Pathology & Laboratory Medicine · doi:10.5858/133.5.743 · Cited by 250
Self-citationDelay to formalin fixation effect on breast biomarkers
Khoury, T., Sait, S., Hwang, H., Chandrasekhar, R., Wilding, G., Tan, D., & Kulkarni, S. (2009) · Modern Pathology · doi:10.1038/modpathol.2009.117 · Cited by 230
Shiffman, R. N., Michel, G., Rosenfeld, R. M., & Davidson, C. (2012) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2011-000172 · Cited by 184
Kim, K. C., Koh, Y. W., Chang, H.-M., Kim, T. H., Yook, J. H., Kim, B. S., Jang, S. J., & Park, Y. S. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-1695-2 · Cited by 175
HER2 Testing in Gastric Cancer
Albarello, L., Pecciarini, L., & Doglioni, C. (2011) · Advances in Anatomic Pathology · doi:10.1097/pap.0b013e3182026d72 · Cited by 172
HER2 testing: Current status and future directions
Perez, E. A., Cortés, J., Gonzalez-Angulo, A. M., & Bartlett, J. M. S. (2014) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2013.09.001 · Cited by 161
Clinical significance of intratumoral HER2 heterogeneity in gastric cancer
Lee, H. E., Park, K. U., Yoo, S. B., Nam, S. K., Park, D. J., Kim, H.-H., & Lee, H. S. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2012.10.018 · Cited by 161
Comparison of HER2 status in primary and paired metastatic sites of gastric carcinoma
Bozzetti, C., Negri, F., Lagrasta, C. A., et al. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.121 · Cited by 154
HER2 Expression in Gastric and Gastroesophageal Junction Adenocarcinoma in a US Population
Kunz, P. L., Mojtahed, A., Fisher, G. A., Ford, J. M., Chang, D. T., Balise, R. R., Bangs, C. D., Cherry, A. M., & Pai, R. K. (2011) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0b013e31821c821c · Cited by 139
Kim, M. A., Lee, H., Yang, H., Bang, Y., & Kim, W. H. (2011) · Histopathology · doi:10.1111/j.1365-2559.2011.04012.x · Cited by 135
Heterogeneity of amplification of HER2, EGFR, CCND1 and MYC in gastric cancer
Stahl, P. R., Seeschaaf, C., Lebok, P., Kutup, A., Bockhorn, M., Izbicki, J. R., Bokemeyer, C., Simon, R., Sauter, G., & Marx, A. H. (2015) · BMC Gastroenterology · doi:10.1186/s12876-015-0231-4 · Cited by 128
Ryu, M., Yoo, C., Kim, J. G., Ryoo, B., Park, Y. S., Park, S. R., Han, H., Chung, I. J., Song, E., Lee, K. H., et al. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2014.12.015 · Cited by 126
Clinical Laboratory Reports in Molecular Pathology
Gulley, M. L., Braziel, R. M., Halling, K. C., Hsi, E. D., Kant, J. A., Nikiforova, M. N., Nowak, J. A., Ogino, S., Oliveira, A. M., Polesky, H. F., et al. (2007) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2007-131-852-clrimp · Cited by 110
Self-citationA study of HER2 gene amplification and protein expression in gastric cancer
Yan, B., Yau, E. X., Omar, S. S. B., Ong, C. W., Pang, B., Yeoh, K. G., & Salto‐Tellez, M. (2010) · Journal of Clinical Pathology · doi:10.1136/jcp.2010.076570 · Cited by 107
Lankshear, S., Srigley, J. R., McGowan, T. S., Yurcan, M., & Sawka, C. A. (2013) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2012-0656-oa · Cited by 105
Park, S. R., Park, Y. S., Ryu, M., Ryoo, B., Woo, C. G., Jung, H., Lee, J. H., Lee, G. H., & Kang, Y. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2015.09.018 · Cited by 104
Yang, J., Luo, H., Li, Y., Li, J., Cai, Z., Su, X., Dai, D., Du, W., Chen, T., & Chen, M. (2011) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-011-9286-1 · Cited by 101
Cho, E. Y., Park, K., Do, I., Cho, J., Kim, J., Lee, J., Kim, S., Kim, S., Kim, K., Sohn, T. S., et al. (2012) · Modern Pathology · doi:10.1038/modpathol.2012.205 · Cited by 93
Okines, A. F. C., Thompson, L. C., Cunningham, D., Wotherspoon, A. C., Reis-Filho, J. S., Langley, R. E., Waddell, T. S., Noor, D., Eltahir, Z., Wong, R., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mds622 · Cited by 93
Yoon, H. H., Shi, Q., Sukov, W. R., Lewis, M. A., Sattler, C. A., Wiktor, A. E., Wu, T., Diasio, R. B., Jenkins, R. B., & Sinicrope, F. A. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.43.1890 · Cited by 92
Hanley, K. Z., Birdsong, G. G., Cohen, C., & Siddiqui, M. T. (2009) · Cancer Cytopathology · doi:10.1002/cncy.20034 · Cited by 88
Shabaik, A. S., Lin, G., Peterson, M. R., Hasteh, F., Tipps, A. M. P., Datnow, B., & Weidner, N. (2010) · Diagnostic Cytopathology · doi:10.1002/dc.21389 · Cited by 86
Quality in Surgical Pathology Communication and Reporting
Nakhleh, R. E. (2011) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2011-0192-ra · Cited by 83
Droplet digital PCR measurement of HER2 in patients with gastric cancer
Kinugasa, H., Nouso, K., Tanaka, T., Miyahara, K., Morimoto, Y., Dohi, C., Matsubara, T., Okada, H., & Yamamoto, K. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.129 · Cited by 82
Advances in the Management of HER2-positive Advanced Gastric and Gastroesophageal Junction Cancer
Bang, Y. (2012) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3182557307 · Cited by 78
Quality assessment of HER2 testing by monitoring of positivity rates
On behalf of the Study Group HER2 Monitor, Choritz, H., Büsche, G., & Kreipe, H. H. (2011) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-011-1132-8 · Cited by 76
Babic, A., Loftin, I. R., Stanislaw, S., Wang, M., Miller, R. M., Warren, S. M., Zhang, W., Lau, A., Miller, M., Wu, P., et al. (2010) · Methods · doi:10.1016/j.ymeth.2010.08.012 · Cited by 73
Genomic assays for Epstein–Barr virus-positive gastric adenocarcinoma
Gulley, M. L. (2015) · Experimental & Molecular Medicine · doi:10.1038/emm.2014.93 · Cited by 71
Self-citationQuality of Life in the Trastuzumab for Gastric Cancer Trial
Satoh, T., Bang, Y., Gotovkin, E., Hamamoto, Y., Kang, Y., Moiseyenko, V. M., Ohtsu, A., Cutsem, E. V., Al-Sakaff, N. J. A., Urspruch, A., et al. (2014) · The Oncologist · doi:10.1634/theoncologist.2014-0058 · Cited by 64
Minimum biopsy set for HER2 evaluation in gastric and gastro-esophageal junction cancer
Gullo, I., Grillo, F., Molinaro, L., Fassan, M., Silvestri, A. D., Tinelli, C., Rugge, M., Fiocca, R., & Mastracci, L. (2015) · Endoscopy International Open · doi:10.1055/s-0034-1391359 · Cited by 57
Feuchtinger, A., Stiehler, T., Jütting, U., Marjanović, G., Luber, B., Langer, R., & Walch, A. K. (2014) · Histochemistry and Cell Biology · doi:10.1007/s00418-014-1258-2 · Cited by 57
Wang, T., Hsieh, E., Henry, P., Hanna, W. M., Streutker, C., & Grin, A. (2014) · Human Pathology · doi:10.1016/j.humpath.2013.12.010 · Cited by 55
Self-citationMillson, A., Suli, A., Hartung, L., Kunitake, S., Bennett, A., Nordberg, M. C. L., Hanna, W., Wittwer, C. T., Seth, A., & Lyon, E. (2003) · The Journal of Molecular Diagnostics · doi:10.1016/s1525-1578(10)60471-0 · Cited by 51
Kinsella, M. D., Birdsong, G. G., Siddiqui, M. T., Cohen, C., & Hanley, K. Z. (2012) · Diagnostic Cytopathology · doi:10.1002/dc.21815 · Cited by 51
Novel targeted agents for gastric cancer
Liu, L., Wu, N., & Li, J. (2012) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-5-31 · Cited by 50
HER2 status in gastroesophageal cancer: a tissue microarray study of 1040 cases
Cappellesso, R., Fassan, M., Hanspeter, E., Bornschein, J., dʼAmore, E. S. G., Cuorvo, L. V., Mazzoleni, G., Barbareschi, M., Pizzi, M., Guzzardo, V., et al. (2015) · Human Pathology · doi:10.1016/j.humpath.2015.02.007 · Cited by 48
Flotillin2 Expression Correlates with HER2 Levels and Poor Prognosis in Gastric Cancer
Zhu, Z., Wang, J., Sun, Z., Sun, X., Wang, Z., & Hui-mian, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062365 · Cited by 41
Effect of HER-2/neu over-expression on prognosis in gastric cancer: a meta-analysis.
Wang, S., Zheng, G., Chen, L., & Xiong, B. (2011) · PubMed · Cited by 41
Saito, T., Nakanishi, H., Mochizuki, Y., Ito, S., Ito, Y., Misawa, K., Yatabe, Y., Yamamichi, K., & Kondo, E. (2014) · Gastric Cancer · doi:10.1007/s10120-014-0417-4 · Cited by 37
Gertych, A., Mohan, S., Maclary, S., et al. (2014) · Diagnostic Pathology · doi:10.1186/s13000-014-0213-9 · Cited by 37
Cho, J., Jeong, J., Sung, J., Sung, C. O., Kim, K., Park, C. K., Choi, M. G., Sohn, T. S., Bae, J. M., & Kim, S. Y. (2012) · Annals of Surgical Oncology · doi:10.1245/s10434-012-2818-0 · Cited by 36
Ge, X., Wang, H., Zeng, H., Jin, X., Sujie, A., Xu, C., Liu, Y., Huang, J., Ji, Y., Tan, Y.-S., et al. (2015) · Human Pathology · doi:10.1016/j.humpath.2015.02.011 · Cited by 32
Kim, M. A., Jung, J. E., Lee, H. E., et al. (2012) · Human Pathology · doi:10.1016/j.humpath.2012.06.022 · Cited by 29
Kanayama, K., Imai, H., Yoneda, M., HIROKAWA, Y. S., & Shiraishi, T. (2016) · Cancer Science · doi:10.1111/cas.12886 · Cited by 29
Pathologic Diagnostics of HER2 Positivity in Gastroesophageal Adenocarcinoma
Koopman, T., Louwen, M., Hage, M., Smits, M. M., & Imholz, A. L. T. (2015) · American Journal of Clinical Pathology · doi:10.1309/ajcpcx69hgddgycq · Cited by 27
Human epidermal growth factor receptor 2 expression in mixed gastric carcinoma
Wang, Y., Chen, Z., Yun, T., Li, C., Jiang, B., Lv, X., Chu, G., Wang, S., Yan, H. H., & Shi, L.-F. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i15.4680 · Cited by 19
Clinicopathological Features and Prognostic Significance of HER2 Expression in Gastric Cancer
Park, J. S., Rha, S. Y., Chung, H. C., Jung, M., Kim, K. H., Jun, H. J., Kim, H., An, J. Y., Kim, H., Cheong, J., et al. (2014) · Oncology · doi:10.1159/000368555 · Cited by 17
Selçukbırıcık, F., Erdamar, S., Büyükünal, E., Serdengeçti, S., & Demirelli, F. H. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.24.10607 · Cited by 13
Wang, T., Amemiya, Y., Henry, P., Seth, A. K., Hanna, W. M., & Hsieh, E. (2015) · Journal of Cancer · doi:10.7150/jca.11424 · Cited by 10
Cited by
Smyth, E. C., Nilsson, M., Grabsch, H. I., van Grieken, N. C., & Lordick, F. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31288-5 · Cited by 4,803
Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Ajani, J. A., D’Amico, T. A., Bentrem, D. J., Chao, J., Cooke, D., Corvera, C., Das, P., Enzinger, P. C., Enzler, T., Fanta, P., et al. (2022) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2022.0008 · Cited by 1,684
Self-citationTrastuzumab deruxtecan in previously treated HER2-positive gastric cancer
Shitara, K., Bang, Y.-J., Iwasa, S., Sugimoto, N., Ryu, M.-H., Sakai, D., Chung, H.-C., Kawakami, H., Yabusaki, H., Lee, J., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2004413 · Cited by 1,333
Ajani, J. A., D’Amico, T. A., Bentrem, D. J., Chao, J., Corvera, C., Das, P., Denlinger, C. S., Enzinger, P. C., Fanta, P., Farjah, F., et al. (2019) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2019.0033 · Cited by 1,059
Self-citationAjani, J. A., Lee, J., Sano, T., Janjigian, Y. Y., Fan, D., & Song, S. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.36 · Cited by 594
Self-citation
Metadata
- Authors
- Bartley, A. N., Washington, M. K., Colasacco, C., Ventura, C. B., Ismaila, N., Benson, A. B., Carrato, A., Gulley, M. L., Jain, D., Kakar, S., Mackay, H. J., Streutker, C., Tang, L., Troxell, M., & Ajani, J. A.
- Venue
- Journal of Clinical Oncology
- Published
- 2017-02-01
- Volume
- 35
- Issue
- 4
- Pages
- 446-464
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2556376431
- Cited by
- 458
- References
- 71
- FWCI
- 13.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.